References
1. Patel AB, Verma A. Covid-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: What is the evidence?JAMA . 2020;323:1769-1770
2. Liu K, Chen Y, Lin R, Han K. Clinical features of covid-19 in elderly patients: A comparison with young and middle-aged patients. J Infect . 2020;80:e14-e18
3. Singhal T. A review of coronavirus disease-2019 (covid-19).Indian J Pediatr . 2020;87:281-286
4. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (covid-19) outbreak - an update on the status. Mil Med Res . 2020;7:11
5. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of sars-cov2 may play a role in the respiratory failure of covid-19 patients. J Med Virol . 2020;92:552-555
6. Rossi GP, Sanga V, Barton M. Potential harmful effects of discontinuing ace-inhibitors and arbs in covid-19 patients.Elife . 2020;9
7. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-em structure of the 2019-ncov spike in the prefusion conformation. Science . 2020;367:1260-1263
8. Rico-Mesa JS, White A, Anderson AS. Outcomes in patients with covid-19 infection taking acei/arb. Curr Cardiol Rep . 2020;22:31
9. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest . 2020;130:2620-2629
10. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. Correlation of chest ct and rt-pcr testing for coronavirus disease 2019 (covid-19) in china: A report of 1014 cases. Radiology . 2020;296:E32-E40
11. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest ct for typical coronavirus disease 2019 (covid-19) pneumonia: Relationship to negative rt-pcr testing. Radiology . 2020;296:E41-E45
12. Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of covid-19. Int J Antimicrob Agents . 2020;55:105955
13. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L. Clinical and biochemical indexes from 2019-ncov infected patients linked to viral loads and lung injury. Sci China Life Sci . 2020;63:364-374
14. Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, Di W, Wang Z, Li Z, Gao H, Liu L, Zhang G. Renin-angiotensin system inhibitors improve the clinical outcomes of covid-19 patients with hypertension.Emerg Microbes Infect . 2020;9:757-760
15. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ace2) in sars coronavirus-induced lung injury. Nat Med . 2005;11:875-879
16. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with covid-19. N Engl J Med . 2020;382:1653-1659
17. Epelman S, Shrestha K, Troughton RW, Francis GS, Sen S, Klein AL, Tang WH. Soluble angiotensin-converting enzyme 2 in human heart failure: Relation with myocardial function and clinical outcomes. J Card Fail . 2009;15:565-571
18. Walters TE, Kalman JM, Patel SK, Mearns M, Velkoska E, Burrell LM. Angiotensin converting enzyme 2 activity and human atrial fibrillation: Increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace . 2017;19:1280-1287
19. Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS One . 2018;13:e0198144
20. Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. Classical renin-angiotensin system in kidney physiology. Compr Physiol . 2014;4:1201-1228
21. Wang X, Khaidakov M, Ding Z, Mitra S, Lu J, Liu S, Mehta JL. Cross-talk between inflammation and angiotensin ii: Studies based on direct transfection of cardiomyocytes with at1r and at2r cdna. Exp Biol Med (Maywood) . 2012;237:1394-1401
22. Hsu WT, Galm BP, Schrank G, Hsu TC, Lee SH, Park JY, Lee CC. Effect of renin-angiotensin-aldosterone system inhibitors on short-term mortality after sepsis: A population-based cohort study.Hypertension . 2020;75:483-491
23. Zhu J, Zhong Z, Li H, Ji P, Pang J, Li B, Zhang J. Ct imaging features of 4121 patients with covid-19: A meta-analysis. J Med Virol . 2020;92:891-902
24. Li K, Chen D, Chen S, Feng Y, Chang C, Wang Z, Wang N, Zhen G. Predictors of fatality including radiographic findings in adults with covid-19. Respir Res . 2020;21:146
25. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The impact of prior outpatient ace inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC Pulm Med . 2005;5:12
26. Myles PR, Hubbard RB, Gibson JE, Pogson Z, Smith CJ, McKeever TM. The impact of statins, ace inhibitors and gastric acid suppressants on pneumonia mortality in a uk general practice population cohort.Pharmacoepidemiol Drug Saf . 2009;18:697-703